Cargando…

Accounting for equity considerations in cost-effectiveness analysis: a systematic review of rotavirus vaccine in low- and middle-income countries

BACKGROUND: Cost-effectiveness analysis (CEA) is frequently used as an input for guiding priority setting in health. However, CEA seldom incorporates information about trade-offs between total health gains and equity impacts of interventions. This study investigates to what extent equity considerati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boujaoude, Marie-Anne, Mirelman, Andrew J., Dalziel, Kim, Carvalho, Natalie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5960127/ https://www.ncbi.nlm.nih.gov/pubmed/29796012 http://dx.doi.org/10.1186/s12962-018-0102-2

Ejemplares similares

Rotavirus vaccine protection in low-income and middle-income countries
por: Ramakrishnan, Girija, et al.
Publicado: (2019)

Systematic Review and Meta-Analysis of Cost-effectiveness of Rotavirus Vaccine in Low-Income and Lower-Middle-Income Countries
por: Haider, Sabbir, et al.
Publicado: (2019)

Balancing safety, efficacy and cost: Improving rotavirus vaccine adoption in low- and middle-income countries
por: Bhan, Anant, et al.
Publicado: (2011)

Poverty reduction and equity benefits of introducing or scaling up measles, rotavirus and pneumococcal vaccines in low-income and middle-income countries: a modelling study
por: Riumallo-Herl, Carlos, et al.
Publicado: (2018)

Capturing Budget Impact Considerations Within Economic Evaluations: A Systematic Review of Economic Evaluations of Rotavirus Vaccine in Low- and Middle-Income Countries and a Proposed Assessment Framework
por: Carvalho, Natalie, et al.
Publicado: (2017)

Update on rotavirus vaccine underperformance in low- to middle-income countries and next-generation vaccines
por: Lee, Benjamin
Publicado: (2020)

Vaccine equity in low and middle income countries: a systematic review and meta-analysis
por: Ali, Huda Ahmed, et al.
Publicado: (2022)

Role of healthcare cost accounting in pricing and reimbursement in low-income and middle-income countries: a scoping review
por: Guinness, Lorna, et al.
Publicado: (2022)

The potential impact of novel tuberculosis vaccines on health equity and financial protection in low-income and middle-income countries
por: Portnoy, Allison, et al.
Publicado: (2023)

Rotavirus Vaccine Schedules and Vaccine Response Among Infants in Low- and Middle-Income Countries: A Systematic Review
por: Gruber, Joann F., et al.
Publicado: (2017)

Healthcare provider perspectives on delivering next generation rotavirus vaccines in five low-to-middle-income countries
por: Mooney, Jessica, et al.
Publicado: (2022)

Correction: Vaccine equity in low and middle income countries: a systematic review and meta-analysis
por: Ahmed Ali, Huda, et al.
Publicado: (2022)

Measuring indirect effects of rotavirus vaccine in low income countries
por: Bennett, Aisleen, et al.
Publicado: (2016)

Data Equity to Advance Health and Health Equity in Low- and Middle-Income Countries: A Scoping Review
por: O‘Neil, So, et al.
Publicado: (2021)

COVID-19 Eradication for Vaccine Equity in Low Income Countries
por: Dharmapalan, Dhanya, et al.
Publicado: (2021)

External funding to strengthen capacity for research in low-income and middle-income countries: exigence, excellence and equity
por: Maher, Dermot, et al.
Publicado: (2020)

Cost-Effectiveness Analysis of COVID-19 Vaccination in Low- and Middle-Income Countries
por: Utami, Auliasari M, et al.
Publicado: (2022)

Mortality reduction benefits and intussusception risks of rotavirus vaccination in 135 low-income and middle-income countries: a modelling analysis of current and alternative schedules
por: Clark, Andrew, et al.
Publicado: (2019)

Methods to promote equity in health resource allocation in low- and middle-income countries: an overview
por: Love-Koh, James, et al.
Publicado: (2020)

Equity in newborn care, evidence from national surveys in low- and middle-income countries
por: Peven, Kimberly, et al.
Publicado: (2021)

Impact of rotavirus vaccine on diarrheal hospitalization and outpatient consultations in the Philippines: First evidence from a middle-income Asian country
por: Lopez, Anna Lena, et al.
Publicado: (2018)

Improving childhood vaccination in low-income and middle-income countries
por: eBioMedicine
Publicado: (2023)

The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study
por: Portnoy, Allison, et al.
Publicado: (2023)

Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models
por: Jit, Mark, et al.
Publicado: (2011)

Trends in vaccine investment in middle income countries
por: Onishchenko, K., et al.
Publicado: (2019)

Estimated economic impact of vaccinations in 73 low- and middle-income countries, 2001–2020
por: Ozawa, Sachiko, et al.
Publicado: (2017)

Defining the Recipe for an Optimal Rotavirus Vaccine Introduction in a High-Income Country in Europe
por: Standaert, Baudouin, et al.
Publicado: (2022)

The Economic Value of Rotavirus Vaccination When Optimally Implemented in a High-Income Country
por: Standaert, Baudouin
Publicado: (2023)

Rotavirus vaccination and intussusception – Science, surveillance, and safety: A review of evidence and recommendations for future research priorities in low and middle income countries
por: Yen, Catherine, et al.
Publicado: (2016)

Evaluating the potential economic and health impact of rotavirus vaccination in 63 middle-income countries not eligible for Gavi funding: a modelling study
por: Debellut, Frédéric, et al.
Publicado: (2021)

Formulation development of a live attenuated human rotavirus (RV3-BB) vaccine candidate for use in low- and middle-income countries
por: Kumar, Prashant, et al.
Publicado: (2021)

Cost-effectiveness of measles and rubella elimination in low-income and middle-income countries
por: Levin, Ann, et al.
Publicado: (2023)

Health Research Profile to assess the capacity of low and middle income countries for equity-oriented research
por: Tugwell, P, et al.
Publicado: (2006)

Improving Equity in Urban Immunization in Low- and Middle-Income Countries: A Qualitative Document Review
por: Belt, Rachel Victoria, et al.
Publicado: (2023)

Pneumococcal conjugate vaccine implementation in middle-income countries
por: Tricarico, Serena, et al.
Publicado: (2017)

Clinical Cancer Genetics in a Lower-Middle Income Country: Considerations for Policymaking
por: Ginsburg, Ophira, et al.
Publicado: (2018)

The Digital Divide in Technologies for Autism: Feasibility Considerations for Low- and Middle-Income Countries
por: Kumm, Aubrey J., et al.
Publicado: (2021)

Considerations for modelling a broad food tax in the Philippines and other low-income and middle-income countries
por: Johnson Curtis, Christine, et al.
Publicado: (2023)

The costs of delivering vaccines in low- and middle-income countries: Findings from a systematic review
por: Vaughan, Kelsey, et al.
Publicado: (2019)

Cost of vaccine delivery strategies in low- and middle-income countries during the COVID-19 pandemic
por: Banks, Christina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sc1lieeakr51meojsskri985hr